tirzepatide statpearls | C225H348N48O68 | CID 156588324 Unveiling Tirzepatide's Therapeutic Spectrum: A

Not quite as good as if you had bought Eli Lilly at the same time (+106%), but much better than the other major GLP-1 stock, Novo Nordisk (incredibly, down 4% since the beginning of 2023)

Use twice daily, morning and evening

That is not the same as approving them

December 18, 2023

A narrow and uniform pore size distribution is indicated by the overlapping adsorption/desorption curves [28]

This threshold is supported by volunteer studies using semaglutide, where residual solids were detected on ultrasound despite 8 h fasting [7], and by matched-pair data showing a five-fold rise in endoscopic residue among GLP-1RA users 7